---
title: "Perspective Therapeutics names Paul Lyne chief science officer as co-founder Schultz moves to advisor role"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292053236.md"
description: "Perspective Therapeutics appointed Paul Lyne as chief science officer, replacing co-founder Michael K. Schultz who transitions to senior scientific advisor for retirement."
datetime: "2026-07-08T10:31:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292053236.md)
  - [en](https://longbridge.com/en/news/292053236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292053236.md)
---

# Perspective Therapeutics names Paul Lyne chief science officer as co-founder Schultz moves to advisor role

-   Perspective Therapeutics appointed Paul Lyne as chief science officer in a management reshuffle announced Tuesday. \* Lyne most recently served as senior vice president, head of oncology research at Merck KGaA, leading a global oncology research organization. \* Co-founder Michael K. Schultz shifted from chief science officer to senior scientific advisor as part of a planned transition toward retirement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CATX.US](https://longbridge.com/en/quote/CATX.US.md)
- [MKKGY.US](https://longbridge.com/en/quote/MKKGY.US.md)

## Related News & Research

- [Perspective Therapeutics, Inc. $CATX Shares Bought by Avidity Partners Management LP](https://longbridge.com/en/news/294575583.md)
- [1,055,409 Shares in Perspective Therapeutics, Inc. $CATX Bought by Yu Fan](https://longbridge.com/en/news/294193695.md)
- [Covivio announces availability of 2026 half-year report](https://longbridge.com/en/news/294781698.md)
- [Apnimed director Paul J. Sekhri acquires $200,000 in common shares](https://longbridge.com/en/news/294730912.md)
- [CNA Financial EVP and CAO Daniel Paul Franzetti sells 22,656 shares worth $1.2 million](https://longbridge.com/en/news/294879995.md)